证券代码：002976 证券简称：瑞玛精密 公告编号：2025-064 励计划实施考核管理办法>的议案》及《关于提请股东大会授权董事会办理 2024 苏州瑞玛精密工业集团股份有限公司 关于 2024 年股票期权激励计划 预留授予登记完成的公告 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 根据中国证监会《上市公司股权激励管理办法》及深圳证券交易所、中国证 券登记结算有限责任公司深圳分公司有关规则的规定，苏州瑞玛精密工业集团股 份有限公司（以下简称"公司"）于 2025 年 7 月 10 日完成了公司 2024 年股票 期权激励计划（以下简称"本激励计划"）股票期权预留授予登记工作。现将有 关事项公告如下： 一、2024 年股票期权激励计划已履行的相关审批程序 于 <苏州瑞玛精密工业集团股份有限公司 ensp="ensp" 年股票期权激励计划="年股票期权激励计划" 草案 ="草案"> 及 其摘要的议案》《关于 <苏州瑞玛精密工业集团股份有限公司 ensp="ensp" 年股票期权激="年股票期权 激"> 年股票期权激励计划相关事宜的议案》。 于 ...

微软发言人表示，此次裁员人数不到公司总员工数的4%，将涵盖不同部门、多个地区以及不 同级别的员工，裁员的主要目的是简化流程和减少管理层级。 不过最近随着多名员工公开发声，微软对被裁员工未归属股票的回收做法被质疑为不公。 前Xbox员工Noble Smith发文称， 他在被裁员时，其尚未归属的公司股票全部被微软回收， 他指出，这些股票的价值"足以供孩子完成大学学业"。 国芯网[原:中国半导体论坛] 振兴国产半导体产业！ 不拘中国、 放眼世界 ！ 关注 世界半导体论坛 ↓ ↓ ↓ 7月10日消息， 微软近日宣布了新的裁员计划，预计将影响到约9000个工作岗位，这是该公 司今年第二次大规模裁员，目的是为了控制成本。 Smith还提到，Xbox并不向开发人员支付作品的版权分成，公司高层将员工签约时获得的股 票和绩效奖金股票视为"等效分成"。 在科技行业，许多公司在雇佣员工时会提供股票激励计划，但大多数股票需要经过一定时间 才能归属。 员工离职或被裁时，未归属的股票通常由公司回收，部分企业会在裁员时，可能将未归属股 票一并发放，但这并非行业标准。 第一步：扫描下方二维码，关注国芯网微信公众号。 目前微软股价已攀升至历史 ...

Group 1 - The company held its sixth meeting of the second supervisory board, which was chaired by Zhang Dan, and the meeting complied with relevant regulations [1] - The supervisory board approved the proposal to use self-owned funds to pay personnel costs for fundraising projects, with plans to later replace these funds with equivalent amounts from the fundraising account, enhancing fund utilization efficiency [1] - The supervisory board also approved the proposal to cancel a portion of stock options from the 2021 stock option incentive plan, totaling 194,000 options, which aligns with the plan's regulations and does not harm the interests of the company or its shareholders [2][3] Group 2 - The voting results for both proposals showed unanimous support, with 3 votes in favor and no votes against or abstentions [2]

Core Viewpoint - The announcement details the first vesting period of the 2024 restricted stock incentive plan for Changzhou Juhe New Materials Co., Ltd, confirming that 1.2715 million shares will vest for 142 eligible participants based on performance criteria [1][10][21] Group 1: Incentive Plan Overview - The total number of restricted shares to be granted under the incentive plan is 3.8 million, accounting for approximately 1.57% of the company's total share capital [1] - The first grant consists of 3.586 million shares, representing about 1.48% of the total share capital at the time of the announcement [1] - The vesting schedule includes three periods: 40% after 12 months, 30% after 24 months, and 30% after 36 months [1][2] Group 2: Performance Assessment Criteria - The performance assessment for the first vesting period requires a revenue growth rate of at least 20% based on 2023 figures [2][3] - The second and third vesting periods have higher targets of 44% and 72.8% revenue growth, respectively [3] - The assessment will also consider the growth rate of photovoltaic conductive silver paste shipments, with similar percentage targets [2][3] Group 3: Vesting Conditions and Procedures - The board confirmed that the first vesting period conditions have been met, allowing for the vesting of 1.2715 million shares [10][21] - The vesting is contingent upon the company not having any adverse audit opinions or regulatory issues in the past year [11][12] - The company will process the vesting and related share registration according to regulatory guidelines [20] Group 4: Stock Grant Details - The adjusted grant price for the restricted shares is set at 18.33 yuan per share, down from 18.74 yuan due to a rights issue [8][9] - A total of 142 individuals are eligible for the first vesting, with specific performance ratings determining individual share allocation [18][19] - The company has invalidated 38.05 thousand shares due to the departure of certain participants [9][15]

Core Points - The announcement details the results of the first vesting period of the 2024 restricted stock incentive plan for the company, with 1,615,000 shares set to be listed on July 16, 2025 [1][8] - The stock is part of an equity incentive program aimed at motivating employees and aligning their interests with those of shareholders [1][2] Summary by Sections Decision Process and Disclosure - The company’s board and supervisory committee have approved the relevant proposals regarding the 2024 restricted stock incentive plan, ensuring compliance with regulatory requirements [2][3] - The supervisory committee verified the list of incentive recipients and issued related opinions [2] Basic Information on Stock Vesting - A total of 127 individuals are eligible for the stock vesting, with 1,615,000 shares being made available for trading [5][8] - The stock originates from a directed issuance of A-share common stock to the incentive recipients [5] Listing and Capital Changes - The total number of shares outstanding will increase from 199,642,250 to 201,257,250 shares following the vesting [7] - The company has received a total of RMB 19,250,800 in subscription payments from the incentive recipients, with the capital increase properly registered [8] Financial Impact - The vesting of 1,615,000 shares represents approximately 0.81% of the total shares before the vesting, and it is expected to dilute earnings per share without significantly impacting the company's financial condition [8]

Core Viewpoint - The company has announced the achievement of vesting conditions for the third vesting period of the initial grant and the second vesting period of the reserved grant under the 2022 Restricted Stock Incentive Plan, allowing a total of 126 individuals to receive shares [1][2][21]. Summary by Sections Incentive Plan Overview - The 2022 Restricted Stock Incentive Plan was approved on July 4, 2022, with a total grant of 2.6 million shares, representing 1.41% of the company's total share capital at the time [2][3]. - The initial grant consisted of 2.25 million shares, with a grant price of 7.64 yuan per share [3][4]. Vesting Conditions and Achievements - For the initial grant's third vesting period, 82 individuals are eligible to receive 1.016668 million shares, while 47 individuals in the reserved grant's second vesting period are eligible for 219,912 shares [2][19]. - The adjusted vesting price is set at 4.28 yuan per share [1][19]. Performance Assessment - The performance assessment for the vesting conditions includes company-level and individual-level evaluations, with specific revenue and net profit growth targets set for the years 2022 to 2024 [5][6][18]. - The company achieved a net profit of approximately 162 million yuan for 2024, reflecting an 83.58% increase compared to 2021, thus meeting the performance criteria for the vesting conditions [18]. Adjustments and Cancellations - Adjustments to the grant price and number of shares have been made over time, with the initial grant price adjusted from 7.64 yuan to 4.28 yuan [15][24]. - A total of 93,140 shares were canceled due to individuals no longer qualifying as incentive recipients [15][23]. Compliance and Approval - The board and supervisory committee have confirmed that the vesting conditions have been met and that the incentive plan complies with relevant laws and regulations [21][23][25]. - The company will continue to fulfill its disclosure obligations as required by law [24][26].

Core Viewpoint - The company announced the cancellation of 194,000 stock options from the 2021 stock option incentive plan due to the departure of one incentive object and the expiration of the exercise period for another group of incentive objects [1][10]. Group 1: Stock Option Incentive Plan - The total number of stock options reserved in the 2021 stock option incentive plan is 5.5 million, with an exercise price set at 4 yuan per registered capital [1]. - The company has made adjustments to the stock option plan, including a reduction in the total number of options to no more than 22 million and a new exercise price of 1 yuan per share [3]. - The board approved the exercise of stock options for 57 incentive objects during the first exercise period, while 320,000 options were canceled due to the departure of 5 incentive objects [4][10]. Group 2: Cancellation of Stock Options - The cancellation of stock options includes 48,000 options from one departing incentive object and 146,000 options that were not exercised by another group after the expiration of their exercise period [10]. - The cancellation aligns with the regulations of the 2021 stock option incentive plan and will not materially affect the company's financial status or operational results [10][11]. - The supervisory board confirmed that the cancellation complies with the relevant provisions of the stock option incentive plan and does not harm the interests of the company or its shareholders [10].

Core Viewpoint - The company, *ST Changfang, has successfully resolved previous audit issues and removed the delisting risk warning, indicating a positive turnaround in its management and operations [1][2]. Group 1: Company Background and Issues - In 2020 and 2021, the subsidiary Kangmingsheng's original management team inflated profits and accounts receivable through undisclosed sales rebates [1]. - The company faced delisting risk warnings due to negative audit reports for the fiscal year 2021 and internal control issues [1]. - In August 2022, the company took over Kangmingsheng and initiated improvements in internal controls, removing the original management team to ensure compliance and stability [1]. Group 2: Remediation and Current Status - By April 2023, the audit firm Zhongxing Caiguanghua confirmed that the issues from the 2021 audit report had been resolved, leading to the application for the removal of the delisting risk warning [2]. - In April 2024, the company received a clean internal control audit report for 2023, further solidifying its compliance status [2]. - The original management team responsible for the issues has been dismissed, and the company has received a formal conclusion on its information disclosure violations [2]. Group 3: Future Outlook - The company plans to implement equity incentives for core personnel by the end of 2024 to enhance management and performance [3]. - It aims to explore various merger and acquisition opportunities while improving operational standards and performance [3]. - The company anticipates leveraging its newly regained status to advance its development and provide returns to investors and society [3].

法律意 中国 深圳 福田区 益田路6001号太平金融大厦11、12楼 邮政 编码：518038 电话（Tel.）：（0755）8826 5288 传真（Fax.）：（0755）8826 5537 网址（Website）：https://www.sundiallawfirm.com 法律意见书 见书 关于深圳市德明利技术股份有限公司 调整预留授予价格及授予数量的 法 律 意 见 书 广东信达律师事务所 关于深圳市德明利技术股份有限公司 调整预留授予价格及授予数量的 法律意见书 信达励字（2025）第 091 号 致：深圳市德明利技术股份有限公司 广东信达律师事务所（以下简称"信达"）根据深圳市德明利技术股份有限公 司（以下简称"公司"）与签订的《专项法律顾问聘请协议》，接受公司委托，担 任公司 2024 年限制性股票激励计划（以下简称"本次激励计划"）的专项法律顾问。 根据《中华人民共和国公司法》《中华人民共和国证券法》《上市公司股权激 励管理办法》（以下简称《管理办法》）、《深圳证券交易所上市公司自律监管指 南第 1 号——业务办理》（以下简称《自律监管指南》）等有关法律、法规和规范 性文件以及《深圳市德明利 ...

《和元生物技术（上海）股份 证券代码：688238 证券简称：和元生物 公告编号：2025-052 和元生物技术（上海）股份有限公司 董事会薪酬与考核委员会关于公司 2025 年限制性股票激励 计划首次授予激励对象名单的审核意见及公示情况说明 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 和元生物技术（上海）股份有限公司（以下简称"公司"）于2025年6月27 日召开了第四届董事会第一次会议，审议通过了《关于公司<2025年限制性股票 激励计划（草案）>及其摘要的议案》等相关议案。根据《上市公司股权激励管 理办法》（以下简称"《管理办法》"）等相关规定，公司对2025年限制性股票 激励计划（以下简称"本次激励计划"）首次授予激励对象名单在公司内部进行 了公示。公司董事会薪酬与考核委员会结合公示情况对拟激励对象进行了核查， 相关公示情况及核查意见如下： 一、公示及核查情况 了《和元生物技术（上海）股份有限公司2025年限制性股票激励计划（草案）》 （以下简称"《激励计划（草案）》"）及其摘要、 有限公司2025年限制性股票 ...